Overview

Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial

Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the effect of Lactobacillus reuteri DSM 17938 administration for the prevention of diarrhea and AAD in children.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Warsaw
Treatments:
Anti-Bacterial Agents